Carregant...
Docetaxel-Carboxymethylcellulose Nanoparticles Display Enhanced Anti-tumor Activity in Murine Models of Castration-Resistant Prostate Cancer
Docetaxel (DTX) remains the only effective drug for prolonging survival and improving quality of life of metastatic castration resistant prostate cancer (mCRPC) patients. Despite some clinical successes with DTX-based therapies, advent of cumulative toxicity and development of drug resistance limit...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4074574/ https://ncbi.nlm.nih.gov/pubmed/24853460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2014.05.021 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|